These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 7038184)
1. [Studies on in vitro antibacterial effects of amoxicillin against Proteus mirabilis IID-994 and Escherichia coli NIHJ JC-2 (author's transl)]. Kochi T; Tachimori Y; Itoh N; Yogo M; Suzuki Y Jpn J Antibiot; 1981 Oct; 34(10):1395-400. PubMed ID: 7038184 [TBL] [Abstract][Full Text] [Related]
2. [Bactericidal activity of amoxicillin. In vitro bactericidal activity and therapeutic effect for experimental infections (author's transl)]. Kamimura T; Okada N; Matsumoto Y; Nishida M Jpn J Antibiot; 1979 Mar; 32(3):364-8. PubMed ID: 374774 [No Abstract] [Full Text] [Related]
3. Resistance to amoxicillin/clavulanate in Escherichia coli. Glupczynski Y; Mac Gillavry G; Yourassowsky E Acta Clin Belg; 1992; 47(5):354-5. PubMed ID: 1334325 [No Abstract] [Full Text] [Related]
4. [Experience in use of amoxicillin for treatment of acute cystitis (author's transl)]. Unno R; Yamamoto Y Jpn J Antibiot; 1976 Jan; 29(1):11-6. PubMed ID: 772243 [TBL] [Abstract][Full Text] [Related]
5. [Escherichia coli eradication from the blader urine by amoxicillin-sulbactam. Intrinsic activity of the inhibitor]. Casellas JM; Visser M; Tomé G; Cohen H; Soutric J; Arenoso H Enferm Infecc Microbiol Clin; 2001 May; 19(5):206-10. PubMed ID: 11446908 [TBL] [Abstract][Full Text] [Related]
6. [Bactericidal activity of amoxicillin and cefaclor in an "in vitro" kinetic model (author's transl)]. Pothier P; Kazmierczak A; Siebor E; Gaillard MC; Pechinot A Ann Microbiol (Paris); 1981; 132(3):293-306. PubMed ID: 7027869 [TBL] [Abstract][Full Text] [Related]
7. [Probability of resistance to 10 standard- and 7 recently introduced antimicrobics in multiresistant strains of Escherichia coli, Proteus mirabilis and klebsiella spec (author's transl)]. Schröter G; Hümpfner A Zentralbl Bakteriol Orig A; 1979 Mar; 243(1):31-42. PubMed ID: 375624 [No Abstract] [Full Text] [Related]
8. [In vitro examination on antibacterial activity of ciclacillin (ACPC) against clinically isolated strains (author's transl)]. Deguchi K Jpn J Antibiot; 1977 May; 30(5):315-20. PubMed ID: 17021 [TBL] [Abstract][Full Text] [Related]
9. [Sensitivity of bacteria inducing urinary infections to 3 drugs (amoxicillin, ampicillin and cephalexin) and clinical efficacy of amoxicillin (author's transl)]. Fukushima S; Fujii H; Kitajima N; Suzuki M Jpn J Antibiot; 1975 Dec; 28(6):795-801. PubMed ID: 1104914 [TBL] [Abstract][Full Text] [Related]
10. [In vitro activity of cefoxitin, a new cephalosporin (author's transl)]. Shah PM; Zwischenbrugger H; Stille W MMW Munch Med Wochenschr; 1976 Nov; 118(45):1469-72. PubMed ID: 825763 [TBL] [Abstract][Full Text] [Related]
11. [Comparison of antibacterial activity of oral antibacterial agents against recently isolated bacteria of E. coli, Klebsiella, Citrobacter and Proteus from clinical materials of urinary tract infection (author's transl)]. Okamoto Y; Maehara K; Ueda Y; Nasu M; Kamiki T; Iri H; Nagai T; Kumamoto Y; Sakai S; Shigeta S; Kosaki N; Oguri T Jpn J Antibiot; 1981 Jun; 34(6):959-75. PubMed ID: 7026823 [No Abstract] [Full Text] [Related]
12. Urinary concentrations and bactericidal activity against amoxicillin-nonsusceptible strains of Escherichia coli with single-dose, oral, sustained-release amoxicillin/clavulanic acid: a phase I, open-label, noncomparative clinical trial in healthy volunteers. Ponte C; Gracia M; Giménez MJ; Aguilar L; Maín CM; Carpintero Y; Huelves L; Carcas A; del Prado G; Soriano F Clin Ther; 2005 Jul; 27(7):1043-9. PubMed ID: 16154483 [TBL] [Abstract][Full Text] [Related]
13. Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis. Tan TY; Ng SY; Teo L; Koh Y; Teok CH J Clin Pathol; 2008 May; 61(5):642-4. PubMed ID: 18057079 [TBL] [Abstract][Full Text] [Related]
14. [In vitro and in vivo antibacterial activity of cephapirin (author's transl)]. Mitsuhashi S; Yaginuma S; Ono H; Kurashige S Jpn J Antibiot; 1974 Apr; 27(2):152-6. PubMed ID: 4211466 [No Abstract] [Full Text] [Related]
15. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field]. Sato Y; Iwata S; Akita H; Murai T; Ibara M; Oikawa T; Osano M Jpn J Antibiot; 1985 Feb; 38(2):327-41. PubMed ID: 3847521 [TBL] [Abstract][Full Text] [Related]
16. [The basic studies on chemotherapy in urinary tract infection due to organisms with resistance to antibiotics (author's transl)]. Igari J Jpn J Antibiot; 1977 Aug; 30(8):596-611. PubMed ID: 409865 [No Abstract] [Full Text] [Related]
17. [Pharmacokinetics of carbenicillin in high dosage (author's transl)]. Höffler D; Koeppe P; Fiegel P; Hölzel D; Ringelmann R; Goeschel U; Palmer WR Dtsch Med Wochenschr; 1974 Mar; 99(9):399-403. PubMed ID: 4208187 [No Abstract] [Full Text] [Related]
18. [Experimental and clinical trials of BRL 25000 (clavulanic acid-amoxicillin) granules in the field of pediatrics]. Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Nishiyama T; Ishimoto K; Tominaga K; Iriki T; Harada M Jpn J Antibiot; 1985 Feb; 38(2):481-506. PubMed ID: 3892076 [TBL] [Abstract][Full Text] [Related]
19. [The distribution of minimal inhibitory concentrations of recently introduced cephalosporins in multiresistant strains of Escherichia coli, Proteus mirabilis and Klebsiella spec. as revealed by zone sizes of a standardized agar diffusion test (author's transl)]. Schröter G; Loch R Zentralbl Bakteriol Orig A; 1979; 245(3):317-23. PubMed ID: 44786 [TBL] [Abstract][Full Text] [Related]
20. [Multiple drug resistance in different medical institutions: frequency and resistance patterns in Escherichia coli, Proteus mirabilis and klebsiella spec (author's transl)]. Schröter G; Hümpfner A Zentralbl Bakteriol Orig A; 1979 Mar; 243(1):43-56. PubMed ID: 375625 [No Abstract] [Full Text] [Related] [Next] [New Search]